Claritev Corporation (CTEV) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Claritev Corporation (CTEV) has a cash flow conversion efficiency ratio of 0.207x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-48.64 Million) by net assets ($-234.41 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of Claritev Corporation to measure how much of total assets are equity-financed.
Claritev Corporation - Cash Flow Conversion Efficiency Trend (2019–2025)
This chart illustrates how Claritev Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is Claritev Corporation's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Claritev Corporation Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Claritev Corporation ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Commercial Bancgroup, Inc. Common Stock
NASDAQ:CBK
|
0.045x |
|
Calfrac Well Services Ltd.
TO:CFW
|
0.114x |
|
Harson Trading China Co Ltd
SHG:603958
|
0.049x |
|
Sweco AB (publ)
ST:SWEC-A
|
-0.005x |
|
Ho Tung Chemical Corp
TW:1714
|
-0.013x |
|
Shenzhen Xfh Technology Co Ltd
SHE:300890
|
-0.022x |
|
Viromed Medical AG
DU:Q11
|
-0.038x |
|
ZheJiang Haers Vacuum Containers Co Ltd
SHE:002615
|
0.076x |
Annual Cash Flow Conversion Efficiency for Claritev Corporation (2019–2025)
The table below shows the annual cash flow conversion efficiency of Claritev Corporation from 2019 to 2025. For the full company profile with market capitalisation and key ratios, see Claritev Corporation market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $-167.18 Million | $117.32 Million | -0.702x | -154.79% |
| 2024-12-31 | $84.02 Million | $107.62 Million | 1.281x | +1174.78% |
| 2023-12-31 | $1.71 Billion | $171.72 Million | 0.100x | -51.69% |
| 2022-12-31 | $1.79 Billion | $372.36 Million | 0.208x | +20.49% |
| 2021-12-31 | $2.34 Billion | $404.69 Million | 0.173x | +16.99% |
| 2020-12-31 | $2.56 Billion | $377.37 Million | 0.148x | +3.02% |
| 2019-12-31 | $1.99 Billion | $284.31 Million | 0.143x | -- |
About Claritev Corporation
Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers claims intelligence solutions, including reference-based pricing, negotiation services, surprise bill services, and Vistara; network solutions, such as primary n… Read more